DOCSLIB.ORG

Bidirectional Binding of Invariant Chain Peptides to an MHC Class II Molecule

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bidirectional Binding of Invariant Chain Peptides to an MHC Class II Molecule Bidirectional binding of invariant chain peptides to an MHC class II molecule Sebastian Günthera,b,1, Andreas Schlundta,1, Jana Stichta, Yvette Roskeb, Udo Heinemannb, Karl-Heinz Wiesmüllerc, Günther Jungc, Kirsten Falkb, Olaf Rötzschkeb,d, and Christian Freunda,2 aLeibniz-Institute for Molecular Pharmacology and Freie Universität Berlin, 13125 Berlin, Germany; bMax-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany; cEMC Microcollections GmbH, D-72070 Tübingen, Germany; and dSingapore Immunology Network, Agency of Science, Technology and Research, Singapore 138648 Edited* by Emil R. Unanue, Washington University, St. Louis, MO, and approved November 2, 2010 (received for review September 30, 2010) T-cell recognition of peptides bound to MHC class II (MHCII) Here we determined the crystal structures of the human MHCII molecules is a central event in cell-mediated adaptive immunity. molecule HLA-DR1 in complex with two CLIP length variants The current paradigm holds that prebound class II-associated in- and observed a unique bidirectional binding mode. NMR analyses variant chain peptides (CLIP) and all subsequent antigens maintain by chemical shift mapping and spin label-induced relaxation en- a canonical orientation in the MHCII binding groove. Here we hancement of the uncatalyzed and HLA-DM edited reactions il- provide evidence for MHCII-bound CLIP inversion. NMR spectroscopy lustrate the dynamic reorientation of the complex in solution. demonstrates that the interconversion from the canonical to the Surface charge distributions differ largely for the two MHC-CLIP inverse alignment is a dynamic process, and X-ray crystallography variants and result in T-cell epitopes with inverted polarity. shows that conserved MHC residues form a hydrogen bond network with the peptide backbone in both orientations. The natural catalyst Results HLA-DM accelerates peptide reorientation and the exchange of Crystal Structures of HLA-DR1/CLIP Reveal Bidirectional Binding. We either canonically or inversely bound CLIP against antigenic peptide. determined the crystal structures of the human MHCII mole- Thus, noncanonical MHC-CLIP displays the hallmarks of a structurally cule HLA-DR1 in complex with the two CLIP length variants and functionally intact antigen-presenting complex. CLIP106–120 and CLIP102–120 (see Fig. 1A for sequences; num- bering refers to the p35 form of invariant chain—see Methods IMMUNOLOGY bidirectional binding | antigen presentation | peptide loading for details). The latter exhibited a canonical peptide alignment showing all of the hallmarks of a conventional MHC–peptide mmune responses against extracellular pathogens rely on anti- complex [Figs. 1B (Right) and C, and 2A; Table S1]: the pocket P1 fi Igen presentation by MHC class II (MHCII) molecules (1). of the MHC molecule is occupied by the rst anchor residue near After endocytosis, exogenous proteins are proteolytically de- the N terminus of the peptide, and side chains 4, 6, and 9 protrude graded in endolysosomal vesicles that also harbor MHCII mole- into the corresponding surface depressions of the MHC binding cules, which at this point are bound to self-peptides originating groove. In contrast, the short CLIP variant was found to bind in an inverse orientation, with the C-terminal methionine accommo- from the invariant chain protein. HLA-DM catalyzed exchange of dated in P and the N-terminal methionine in P [Fig. 1B (Left) and class II-associated invariant chain peptides (CLIP) for pathogen- 1 9 C, and Table S1]. Whereas co-refolded HLA-DR1/CLIP – derived peptides of higher affinity then leads to the formation and 102 120 – crystallized at room temperature, crystals showing the inverted surface presentation of immunogenic MHCII peptide complexes orientation only grew at the same temperature when HLA-DR1 (2). However, evidence is mounting that CLIP function extends was refolded without any peptide and subsequently loaded with beyond its placeholder properties: stable MHCII–CLIP com- CLIP106–120. However, when changing the conditions to refolding plexes are up-regulated on dendritic cells upon maturation and HLA-DR1 in the presence of CLIP106–120 and crystallizing the modulate the activation of T cells specific for exogenous foreign complex at low temperatures (SI Materials and Methods)we antigen (3). The continued presentation of CLIP on the surface of could additionally determine the structure of canonically aligned antigen presenting cells requires the active maintenance of pe- CLIP106–120 bound to the MHC (Fig. S1). ripheral tolerance against self (4). MHC alleles susceptible to In-depth comparison of the three structures analyzed here autoimmune diseases, in contrast, are associated with low affini- reveals as a striking feature the preservation of a dense hydrogen ties for, and thus low surface levels of, CLIP (5). Taken together, bond network in both orientations (Fig. S2A). This particular the presence of the self-peptide CLIP on the cell surface seems to feature of peptide–MHC complexes is mediated by MHC side shape the T-cell repertoire in vivo, which, as observed for other chains that interact with the peptide backbone and, hence, is pep- peptides as well, has additionally been shown to be influenced by tide-sequence independent. Surprisingly, almost no rearrangement N-terminal length variations (6, 7). of MHC side chains is necessary to preserve the network in the The MHCII–peptide binding mode might account for these inverted orientation, and the pseudosymmetry of the polyproline observations. Peptides are assumed to bind in a conserved N- to type II helix ensures the availability of CO and NH peptide back- C-terminal orientation by two governing principles: (i) a set of hydrogen bonds between the peptide backbone and MHC side chains; and (ii) the geometrically and chemically favorable ac- Author contributions: S.G., A.S., J.S., O.R., and C.F. designed research; S.G., A.S., J.S., and fi fi Y.R. performed research; S.G., A.S., J.S., Y.R., U.H., K.-H.W., G.J., K.F., O.R., and C.F. commodation of four to ve peptide side chains by de ned MHC analyzed data; and S.G., A.S., J.S., and C.F. wrote the paper. – surface pockets (8). The observation that single peptide MHC The authors declare no conflict of interest. complexes can elicit functionally distinct immune responses has *This Direct Submission article had a prearranged editor. been attributed to distinct peptide binding registers (9, 10) or the Data deposition: The structures reported in this paper have been deposited in the Protein existence of different conformational isomers of the MHCII itself Data Bank database (accession nos. 3PDO, 3PGC, and 3PGD). (11, 12). However, because X-ray crystallography might not cap- 1S.G. and A.S. contributed equally to this work. ture the dynamic rearrangements that accompany alternative 2To whom correspondence should be addressed. E-mail: [email protected]. fi complex formation, the molecular basis for these ndings is still This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. poorly understood. 1073/pnas.1014708107/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1014708107 PNAS Early Edition | 1of6 Downloaded by guest on September 25, 2021 Fig. 1. Crystal structures of HLA-DR1 bound to two CLIP length variants. (A) Amino acid sequences of CLIP variants used in this study. (B) Left: Crystal structure of HLA-DR1 bound to CLIP106–120 showing the peptide fragment in an atypical inverted orientation, as indicated by the arrow. Right: Analogous view onto the crystal structure of HLA-DR1 bound to CLIP102–120 in the canonical orientation. Both structures are shown as semitransparent surface (white) top view onto α1β1 domains, with the ribbon presentation embedded. The relative positions of the membrane distal domains are indicated. Peptides are displayed as sticks. (C) Upper: Lateral cut of the binding groove of HLA-DR1 (peptide removed), highlighting the antigen-binding pockets P1 and P9. Lower: 2Fo-Fc electron density maps (contoured at 1σ) of peptides derived from the crystal structure of HLA-DR1/CLIP106–120,flipped and HLA-DR1/CLIP102–120 are shown from the same per- spective inside the binding groove. Both peptides appear with two methionine side chains sequestered into the respective P1 and P9 pockets, as indicated. bone atoms as hydrogen bonding partners (Fig. S2 A and B and bilizing interface is missing. However, upon peptide inversion Table S2). In the reverse peptide orientation an additional H-bond these hydrogen bonds are reestablished (Fig. 2). Interestingly, the between the side chain carbonyl group of αN62 and the backbone only other available MHCII–CLIP structures are of longer CLIP NH group of P5 of the peptide can be formed (Fig. 2A and Fig. variants that are able to form these critical N-terminal hydro- S2A). The central threonine at P5 acts as point of symmetry, with gen bonds and display a canonical peptide orientation (13, 14). methionine occupying P1 and P9 and promiscuous binding of either alanine or proline at positions P4 and P6 (Fig. 1 A and C). Peptide Inversion Monitored by NMR Chemical Shift Analysis of HLA- A likely explanation for the observed peptide inversion is DR1/CLIP106–120. To ensure that bidirectional peptide alignment is revealed by a closer analysis of the hydrogen bond network not due to constraints imposed by the crystallization process, around P−2 of the MHC. At this position CLIP102–120 is engaged analysis of MHC-ligand complexes was carried out in solution. in three hydrogen bonds with the MHCII residues αF51 and The only spectroscopic method to yield such information at the αS53. In the canonical HLA-DR1/CLIP106–120 complex this sta- atomic level is NMR. Using an optimized refolding procedure 2of6 | www.pnas.org/cgi/doi/10.1073/pnas.1014708107 Günther et al. Downloaded by guest on September 25, 2021 Fig. 3. Dynamic behavior of the HLA-DR1/CLIP106–120 complex. (A) Close-up view from crystal structures of HLA-DR1/CLIP106–120 with canonical (blue) and inverted (red) peptide orientation.
Load more

Recommended publications
  • Selection in the Thymus Stromal Cell Type in Positive and Negative
    Differential Effects of Peptide Diversity and Stromal Cell Type in Positive and Negative Selection in the Thymus This information is current as Graham Anderson, Katharine M. Partington and Eric J. of September 29, 2021. Jenkinson J Immunol 1998; 161:6599-6603; ; http://www.jimmunol.org/content/161/12/6599 Downloaded from References This article cites 31 articles, 9 of which you can access for free at: http://www.jimmunol.org/content/161/12/6599.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 29, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Differential Effects of Peptide Diversity and Stromal Cell Type in Positive and Negative Selection in the Thymus1 Graham Anderson,2 Katharine M. Partington, and Eric J. Jenkinson Thymocyte positive selection results in maturation to the single-positive stage, while negative selection results in death by apo- ptosis. Although kinetic analyses indicate only 3–5% of CD4181 cells reach the single-positive stage, the balance of positive and negative selection and the nature and quantity of cells mediating maximal negative selection are uncertain.
    [Show full text]
  • Class II Allotypes Promiscuous Binding of Invariant Chain to MHC
    Identification of a Sequence That Mediates Promiscuous Binding of Invariant Chain to MHC Class II Allotypes1 Ina M. Siebenkotten, Cornelia Carstens, and Norbert Koch2 The invariant chain (Ii) shows promiscuous binding to a great variety of MHC class II allotypes. In contrast, the affinities of the Ii-derived fragments, class II-associated Ii peptides, show large differences in binding to class II allotypes. The promiscuous association of Ii to all class II polypeptides therefore requires an additional contact site to stabilize the interaction to the poly- morphic class II cleft. We constructed recombinant molecules containing the class II binding site of Ii (CBS) and tested their association with HLA-DR dimers. The CBS fused to the transferrin receptor mediates binding of transferrin receptor-CBS to class II dimers. Within the CBS, deletion of a sequence N-terminal to the groove-binding motif abolished binding of Ii to DR. A promiscuous class II binding site was identified by reinsertion of the N-terminal residues, amino acids 81–87, of Ii into an Ii mutant that lacks the groove-binding segment. DR allotype-dependent association of Ii was achieved by insertion of antigenic sequences. The promiscuous association, in contrast to the class II allotype-dependent binding of Ii, is important to prevent interaction of class II dimers to nascent polypeptides in the endoplasmic reticulum. The Journal of Immunology, 1998, 160: 3355–3362. he first indication that the invariant chain (Ii)3 plays a groove, whereas the N terminus of the Ii fragment is disordered in functional role in Ag processing was obtained with Ii- the crystal (21).
    [Show full text]
  • Endosomal/Lysosomal Compartments Receptor and Modulates Its
    The MHC Class II-Associated Invariant Chain Interacts with the Neonatal Fc γ Receptor and Modulates Its Trafficking to Endosomal/Lysosomal Compartments This information is current as of October 2, 2021. Lilin Ye, Xindong Liu, Subrat N. Rout, Zili Li, Yongqi Yan, Li Lu, Tirumalai Kamala, Navreet K. Nanda, Wenxia Song, Siba K. Samal and Xiaoping Zhu J Immunol 2008; 181:2572-2585; ; doi: 10.4049/jimmunol.181.4.2572 Downloaded from http://www.jimmunol.org/content/181/4/2572 References This article cites 68 articles, 35 of which you can access for free at: http://www.jimmunol.org/content/181/4/2572.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 2, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The MHC Class II-Associated Invariant Chain Interacts with the Neonatal Fc␥ Receptor and Modulates Its Trafficking to Endosomal/Lysosomal Compartments1 Lilin Ye,*§ Xindong Liu,*§ Subrat N.
    [Show full text]
  • Evolution of Male Pregnancy Associated with Remodeling of Canonical Vertebrate Immunity in Seahorses and Pipefishes
    Evolution of male pregnancy associated with remodeling of canonical vertebrate immunity in seahorses and pipefishes Olivia Rotha,1, Monica Hongrø Solbakkenb, Ole Kristian Tørresenb, Till Bayera, Michael Matschinerb,c, Helle Tessand Baalsrudb, Siv Nam Khang Hoffb, Marine Servane Ono Brieucb, David Haasea, Reinhold Haneld, Thorsten B. H. Reuscha,2, and Sissel Jentoftb,2 aMarine Evolutionary Ecology, GEOMAR Helmholtz Centre for Ocean Research Kiel, D-24105 Kiel, Germany; bCentre for Ecological and Evolutionary Synthesis, Department of Biosciences, University of Oslo, NO-0371 Oslo, Norway; cDepartment of Palaeontology and Museum, University of Zurich, CH-8006 Zürich, Switzerland; and dThünen Institute of Fisheries Ecology, D-27572 Bremerhaven, Germany Edited by Günter P. Wagner, Yale University, New Haven, CT, and approved March 13, 2020 (received for review September 18, 2019) A fundamental problem for the evolution of pregnancy, the most class I and II genes (7–9) plays a key role for self/nonself-recognition. specialized form of parental investment among vertebrates, is the While in mammals an initial inflammation seems crucial for embryo rejection of the nonself-embryo. Mammals achieve immunological implantation (10), during pregnancy mammals prevent an immuno- tolerance by down-regulating both major histocompatibility com- logical rejection of the embryo with tissue layers of specialized fetal plex pathways (MHC I and II). Although pregnancy has evolved cells, the trophoblasts (11–13). Trophoblasts do not express MHC II multiple times independently among vertebrates, knowledge of (14–16) and thus prevent antigen presentation to maternal T-helper associated immune system adjustments is restricted to mammals. (Th) cells (17), which otherwise would trigger an immune response All of them (except monotremata) display full internal pregnancy, against nonself.
    [Show full text]
  • Binding of Major Histocompatibility Complex Class 1I to the Invariant
    Binding of Major Histocompatibility Complex Class 1I to the Invariant Chain-derived Peptide, CLIP, Is Regulated by Allelic Polymorphism in Class 1I By Alessandro Sette,* Scott Southwood,* Jim Miller, and Ettore Appella$ From the "Department of Immunology, Cytel, San Diego, CA 92121; the *Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois 60637-1432; and SNational Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Summary Major histocompatibility complex class II-associated invariant chain (Ii) provides several important functions that regulate class II expression and function. One of these is the ability to inhibit class II peptide loading early in biosynthesis. This allows for efficient class II folding and egress from the endoplasmic reticulum, and protects the class II peptide binding site from loading with peptides before entry into endosomal compartments. The ability of Ii to interact with class II and interfere with peptide loading has been mapped to Ii exon 3, which encodes amino acids 82-107. This same region of Ii has been described as a nested set of class II-associated Ii peptides (CLIPs) that are transiently associated with class II in normal cells and accumulate in human histocompatibility leukocyte antigen-DM-negative cell lines. Currently it is not clear how CLIP and the CLIP region of Ii blocks peptide binding. CLIP may bind directly to the class II peptide binding site, or may bind elsewhere on class II and modulate class II peptide binding a11osterically. In this report, we show that CLIP can interact with many different murine and human class II molecules, but that the affinity of this interaction is controlled by polymorphic residues in the class II chains.
    [Show full text]
  • Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome
    [CANCER RESEARCH 64, 5546–5550, August 15, 2004] Advances in Brief Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome Martine E. D. Chamuleau,1 Yuri Souwer,3,4,5 S. Marieke van Ham,4 Adri Zevenbergen,1 Theresia M. Westers,1 Johannes Berkhof,2 Chris J. L. M. Meijer,3 Arjan A. van de Loosdrecht,1 and Gert J. Ossenkoppele1 Departments of 1Hematology, 2Clinical Epidemiology and Biostatistics, and 3Pathology, VU University Medical Center, Amsterdam, the Netherlands; 4Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; 5Department of Immunopathology, Sanquin Research at Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, the Netherlands Abstract CLIP correlates with a high DO:DM ratio and can be viewed as an indicator for low effectiveness of antigen presentation (8). ؉ Effective antitumor responses need the activation of CD4 T cells. In MHC class II negative tumors, the activation of CD4ϩ T cells MHC class II antigen presentation requires the release of class II-associ- relies on presentation of tumor antigens by professional antigen- ated invariant chain peptide (CLIP) from the antigen-binding site. In presenting cells (APCs). MHC class II transfection studies in mice antigen-presenting cells, human leukocyte antigen DM (HLA-DM; abbre- viated DM in this article) catalyzes CLIP dissociation. In B cells, HLA-DO have shown that, upon expression of MHC class II molecules, tumor ϩ (DO) down-modulates DM function. Cell surface CLIP:HLA-DR (DR) cells can present their tumor antigens directly to CD4 T cells, thus ratio correlates to DO:DM ratio and the efficacy of antigen presentation.
    [Show full text]
  • Ancient Features of the MHC Class II Presentation Pathway, and a Model for the Possible Origin of MHC Molecules
    Immunogenetics (2019) 71:233–249 https://doi.org/10.1007/s00251-018-1090-2 REVIEW Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules Johannes M. Dijkstra1 & Takuya Yamaguchi2 Received: 16 August 2018 /Accepted: 6 October 2018 /Published online: 30 October 2018 # Springer-Verlag GmbH Germany, part of Springer Nature 2018 Abstract Major histocompatibility complex (MHC) molecules are only found in jawed vertebrates and not in more primitive species. MHC class II type structures likely represent the ancestral structure of MHC molecules. Efficient MHC class II transport to endosomal compartments depends on association with a specialized chaperone, the MHC class II invariant chain (aliases Ii or CD74). The present study identifies conserved motifs in the CLIP region of CD74 molecules, used for binding in the MHC class II binding groove, throughout jawed vertebrates. Peculiarly, in CD74a molecules of Ostariophysi, a fish clade including for example Mexican tetra and zebrafish, the CLIP region has duplicated. In mammals, in endosomal compartments, the peptide-free form of classical MHC class II is stabilized by binding to nonclassical MHC class II BDM,^ a process that participates in Bpeptide editing^ (selection for high affinity peptides). Hitherto, DM-lineage genes had only been reported from the level of amphibians, but the present study reveals the existence of DMA and DMB genes in lungfish. This is the first study which details how classical and DM lineage molecules have distinguishing glycine-rich motifs in their transmembrane regions. In addition, based on extant MHC class II structures and functions, the present study proposes a model for early MHC evolution, in which, in an ancestral jawed vertebrate, the ancestral MHC molecule derived from a heavy-chain-only antibody type molecule that cycled between the cell surface and endosomal compartments.
    [Show full text]
  • Assembly, Maturation, and Function Mutant HLA-DM Molecule
    Aberrant Intermolecular Disulfide Bonding in a Mutant HLA-DM Molecule: Implications for Assembly, Maturation, and Function This information is current as Robert Busch, Robert C. Doebele, Emily von Scheven, Jimothy of September 28, 2021. Fahrni and Elizabeth D. Mellins J Immunol 1998; 160:734-743; ; http://www.jimmunol.org/content/160/2/734 Downloaded from References This article cites 51 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/160/2/734.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Aberrant Intermolecular Disulfide Bonding in a Mutant HLA-DM Molecule: Implications for Assembly, Maturation, and Function1 Robert Busch,2* Robert C. Doebele,† Emily von Scheven,‡ Jimothy Fahrni,* and Elizabeth D. Mellins* HLA-DM (abbreviated DM) is an MHC-encoded glycoprotein that catalyzes the selective release of peptides, including class II-associated invariant chain peptides, from MHC class II molecules.
    [Show full text]
  • RA0066-C.5-IFU-RUO CD74 (B-Cell Marker); Clone CLIP/813
    Instructions For Use RA00 66 -C.5 -IFU -RUO Revision: 1 Rev. Date: Oct. 3, 2014 Page 1 of 2 P.O. Box 3286 - Logan, Utah 84323, U.S.A. - Tel. (800) 729-8350 – Tel. (435) 755-9848 - Fax (435) 755-0015 - www.scytek.com CD74 (B-Cell Marker); Clone CLIP/813 (Concentrate) Availability/Contents: Item # Volume RA0066-C.5 0.5 ml Description: Species: Mouse Immunogen: Recombinant human CD74 protein Clone: CLIP/813 Isotype: IgG1, kappa Entrez Gene ID: 972 (Human) Hu Chromosome Loc.: 5q33.1 Synonyms: CLIP, DHLAG, Gamma chain of class II antigens, HLA class II histocompatibility antigen gamma chain, HLA-DR antigens-associated invariant chain, HLADR-gamma (HLADG), Ia antigen-associated invariant chain, la-gamma, Major histocompatibility complex class II invariant chain, MHC HLA-DR gamma chain Mol. Weight of Antigen: 33-41kDa Format: 200µg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Specificity: This monoclonal antibody recognizes a protein of ~35kDa, identified as CD74. Background: CD74 is a type II transmembrane protein which binds to the peptide binding groove of newly synthesized MHC class II alpha/beta heterodimers and prevents their premature association with endogenous polypeptides. CD74 is expressed primarily by antigen presenting cells, such as B-lymphocytes (from before the pre-B cell stage to before the plasma cell stage), macrophages, monocytes, and many epithelial cells. Anti-CD74 stains predominantly germinal center lymphocytes and B-cell lymphomas, but rarely T-cell lymphomas. Anti-CD74 has been shown to be useful in differentiating atypical fibroxanthoma (-) from malignant fibrous histiocytoma (+).
    [Show full text]
  • Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression
    Hindawi Publishing Corporation Journal of Nutrition and Metabolism Volume 2016, Article ID 4280876, 8 pages http://dx.doi.org/10.1155/2016/4280876 Research Article Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression on Activated B-Lymphocytes: A Plausible Mechanism for Downregulation of Acute Inflammatory Conditions Omar K. Danner,1 Leslie R. Matthews,1 Sharon Francis,1 Veena N. Rao,1 Cassie P. Harvey,2 Richard P. Tobin,2 Ken L. Wilson,3 Ernest Alema-Mensah,1 M. Karen Newell Rogers,2 and Ed W. Childs1 1 Morehouse School of Medicine, Atlanta, GA, USA 2Texas A&M School of Medicine, Temple, TX, USA 3Michigan State University College of Human Medicine, Flint, MI, USA Correspondence should be addressed to Omar K. Danner; [email protected] Received 24 December 2015; Revised 17 March 2016; Accepted 18 April 2016 Academic Editor: Azeddine Ibrahimi Copyright © 2016 Omar K. Danner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Class II invariant chain peptide (CLIP) expression has been demonstrated to play a pivotal role in the regulation of B cell function after nonspecific polyclonal expansion. Several studies have shown vitamin D3 helps regulate the immune response. We hypothesized that activated vitamin D3 suppresses CLIP expression on activated B-cells after nonspecific activation or priming of C57BL/6 mice with CpG. This study showed activated vitamin D3 actively reduced CLIP expression and decreased the number + of CLIP B-lymphocytes in a dose and formulation dependent fashion.
    [Show full text]
  • Specific Treatment of Autoimmunity with Recombinant Invariant Chains in Which CLIP Is Replaced by Self-Epitopes
    Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes Felix Bischof*†‡§, Wolfgang Wienhold†‡, Christoph Wirblich†, Georg Malcherek†, Olayinka Zevering*, Ada M. Kruisbeek*, and Arthur Melms† *Division of Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands; and †Department of Neurology, University of Tu¨bingen, 72076 Tu¨bingen, Germany Edited by Michael Sela, Weizmann Institute of Science, Rehovot, Israel, and approved August 23, 2001 (received for review May 4, 2001) The invariant chain (Ii) binds to newly synthesized MHC class II antigen-specific tolerance and preventing EAE. Importantly, i.v. molecules with the CLIP region of Ii occupying the peptide-binding injection of Ii-MBP84–96 or Ii-PLP139–151 after disease induc- groove. Here we demonstrate that recombinant Ii proteins with tion completely suppressed EAE, demonstrating the qualities of the CLIP region replaced by antigenic self-epitopes are highly recombinant Ii proteins as potent antigen delivery systems for efficient in activating and silencing specific T cells in vitro and in the treatment of autoimmunity. vivo. The Ii proteins require endogenous processing by antigen- presenting cells for efficient T cell activation. An Ii protein encom- Materials and Methods passing the epitope myelin basic protein amino acids 84–96 (Ii- Mice. SJL mice were bred under specific pathogen-free condi- MBP84–96) induced the model autoimmune disease experimental tions at the Netherlands Cancer Institute. In all experiments, 8- allergic encephalomyelitis (EAE) with a higher severity and earlier to 12-week-old female mice were used according to approved onset than the peptide. When applied in a tolerogenic manner, protocols.
    [Show full text]
  • Lacking Invariant Chain and DM Functions MHC Class II Expression
    MHC Class II Expression in Double Mutant Mice Lacking Invariant Chain and DM Functions George Kenty, W. David Martin, Luc Van Kaer and Elizabeth K. Bikoff This information is current as of September 28, 2021. J Immunol 1998; 160:606-614; ; http://www.jimmunol.org/content/160/2/606 References This article cites 84 articles, 37 of which you can access for free at: Downloaded from http://www.jimmunol.org/content/160/2/606.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on September 28, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. MHC Class II Expression in Double Mutant Mice Lacking Invariant Chain and DM Functions1 George Kenty,* W. David Martin,2† Luc Van Kaer,3† and Elizabeth K. Bikoff4* Invariant (Ii) chain and DM functions are required at distinct stages during class II maturation to promote occupancy by diverse peptide ligands.
    [Show full text]